154 related articles for article (PubMed ID: 1762378)
21. Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.
Kuglin B; Bertrams J; Linke C; Gries FA; Kolb H
Klin Wochenschr; 1989 Jan; 67(2):66-73. PubMed ID: 2646470
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children.
Carel JC; Boitard C; Eisenbarth G; Bach JF; Bougnères PF
J Autoimmun; 1996 Dec; 9(6):739-45. PubMed ID: 9115576
[TBL] [Abstract][Full Text] [Related]
23. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
European Nicotinamide Diabetes Intervention Trial Group
Diabetologia; 2003 Mar; 46(3):339-46. PubMed ID: 12687331
[TBL] [Abstract][Full Text] [Related]
24. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
25. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
26. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes.
Eisenbarth GS; Jackson RA; Pugliese A
J Autoimmun; 1992 Apr; 5 Suppl A():241-6. PubMed ID: 1503616
[TBL] [Abstract][Full Text] [Related]
27. Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes.
Dean BM; Becker F; McNally JM; Tarn AC; Schwartz G; Gale EA; Bottazzo GF
Diabetologia; 1986 May; 29(5):339-42. PubMed ID: 3522332
[TBL] [Abstract][Full Text] [Related]
28. 64,000 Mr autoantibodies as predictors of insulin-dependent diabetes.
Atkinson MA; Maclaren NK; Scharp DW; Lacy PE; Riley WJ
Lancet; 1990 Jun; 335(8702):1357-60. PubMed ID: 1971659
[TBL] [Abstract][Full Text] [Related]
29. [Etiology and pathogenesis of insulin-dependent diabetes mellitus].
Klöppel G; Clemens A
Verh Dtsch Ges Pathol; 1996; 80():93-103. PubMed ID: 9065059
[TBL] [Abstract][Full Text] [Related]
30. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
Bingley PJ
Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
Harrison LC; Honeyman MC; Steele CE; Stone NL; Sarugeri E; Bonifacio E; Couper JJ; Colman PG
Diabetes Care; 2004 Oct; 27(10):2348-55. PubMed ID: 15451899
[TBL] [Abstract][Full Text] [Related]
32. Anti-sympathetic ganglia antibodies and postural blood pressure in IDDM subjects of varying duration and patients at high risk of developing IDDM.
Rabinowe SL; Brown FM; Watts M; Kadrofske MM; Vinik AI
Diabetes Care; 1989 Jan; 12(1):1-6. PubMed ID: 2653745
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to proinsulin and insulin as predictive markers of type 1 diabetes.
Kuglin B; Rjasanowski I; Bertrams J; Gries FA; Kolb H; Michaelis D
Diabet Med; 1990 May; 7(4):310-4. PubMed ID: 2140083
[TBL] [Abstract][Full Text] [Related]
34. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
35. Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects.
Mauricio D; Corcoy R; Codina M; Morales J; Balsells M; de Leiva A
Diabet Med; 1995 Nov; 12(11):1009-14. PubMed ID: 8582122
[TBL] [Abstract][Full Text] [Related]
36. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
[TBL] [Abstract][Full Text] [Related]
37. Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes.
Bleich D; Jackson RA; Soeldner JS; Eisenbarth GS
Diabetes Care; 1990 Feb; 13(2):111-8. PubMed ID: 2190768
[TBL] [Abstract][Full Text] [Related]
38. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients.
Ziegler AG; Standl E; Albert E; Mehnert H
Diabetes; 1991 Sep; 40(9):1146-9. PubMed ID: 1936622
[TBL] [Abstract][Full Text] [Related]
39. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.
Achenbach P; Koczwara K; Knopff A; Naserke H; Ziegler AG; Bonifacio E
J Clin Invest; 2004 Aug; 114(4):589-97. PubMed ID: 15314696
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
